2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow DEKK-TEC, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DM-CHOC-PEN for Brain Tumors in AYA Subjects DM-CHOC-PEN - Advanced Cancer, Brain Metastases | Phase 2 | Completed | DEKK-TEC, Inc. | 20 | 2019-01-01 | 2022-11-08 |
| Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors 4-Demethyl-4-cholestryloxycarbonylpenclomedine - Primary Brain Tumors, Metastatic Malignant Neoplasm to Brain | Phase 2 | Completed | DEKK-TEC, Inc. | 29 | 2013-09-01 | 2020-09-16 |
Brain Neoplasms (2) · Breast Neoplasms (1) · Glioblastoma (1) · Lung Neoplasms (1) · Melanoma (1)
United States (2)
Ali Baghian, MD (1) · Lee R Morgan, MD, PhD (1) · Marcus L Ware, MD (1) · Tallat Mahmmod, MD (1)
R44CA125871 (1)